Found: 100
Select item for more details and to access through your institution.
A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 5, p. 473, doi. 10.1007/s12185-014-1672-1
- By:
- Publication type:
- Article
IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 6, p. 793, doi. 10.1007/s12185-013-1345-5
- By:
- Publication type:
- Article
Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 3, p. 382, doi. 10.1007/s12185-013-1270-7
- By:
- Publication type:
- Article
Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 1, p. 92, doi. 10.1007/s12185-012-1237-0
- By:
- Publication type:
- Article
Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 3, p. 327, doi. 10.1007/s12185-012-1142-6
- By:
- Publication type:
- Article
Polymyositis and myocarditis after donor lymphocyte infusion.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells.
- Published in:
- Journal of Immunology Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/706379
- By:
- Publication type:
- Article
Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 303, doi. 10.1111/bjh.16381
- By:
- Publication type:
- Article
A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 707, doi. 10.1111/bjh.14701
- By:
- Publication type:
- Article
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 62, doi. 10.1111/bjh.12492
- By:
- Publication type:
- Article
H2AFX Polymorphisms Are Associated with Decreased Risk of Diffuse Large B Cell Lymphoma in Koreans.
- Published in:
- DNA & Cell Biology, 2011, v. 30, n. 12, p. 1039, doi. 10.1089/dna.2010.1130
- By:
- Publication type:
- Article
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
- Published in:
- Journal of Clinical Apheresis, 2014, v. 29, n. 6, p. 305, doi. 10.1002/jca.21326
- By:
- Publication type:
- Article
Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
- Published in:
- Journal of Clinical Apheresis, 2006, v. 21, n. 4, p. 233, doi. 10.1002/jca.20105
- By:
- Publication type:
- Article
The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
- Published in:
- Journal of Clinical Apheresis, 2004, v. 19, n. 3, p. 130, doi. 10.1002/jca.20015
- By:
- Publication type:
- Article
Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2004, v. 19, n. 2, p. 66, doi. 10.1002/jca.10080
- By:
- Publication type:
- Article
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221113789
- By:
- Publication type:
- Article
Naïve CD8<sup>+</sup> T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment.
- Published in:
- Scientific Reports, 2016, p. 28208, doi. 10.1038/srep28208
- By:
- Publication type:
- Article
Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01370
- By:
- Publication type:
- Article
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2309, doi. 10.1007/s00277-018-3458-7
- By:
- Publication type:
- Article
Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 955, doi. 10.1007/s00277-018-3260-6
- By:
- Publication type:
- Article
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decreased body mass index is associated with poor prognosis in patients with multiple myeloma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 835, doi. 10.1007/s00277-013-1977-9
- By:
- Publication type:
- Article
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 6, p. 789, doi. 10.1007/s00277-013-1685-5
- By:
- Publication type:
- Article
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 4, p. 471, doi. 10.1007/s00277-012-1640-x
- By:
- Publication type:
- Article
Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 4, p. 459, doi. 10.1007/s00277-012-1635-7
- By:
- Publication type:
- Article
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 2, p. 163, doi. 10.1007/s00277-012-1580-5
- By:
- Publication type:
- Article
A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 7, p. 1023, doi. 10.1007/s00277-012-1420-7
- By:
- Publication type:
- Article
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 12, p. 1419, doi. 10.1007/s00277-011-1219-y
- By:
- Publication type:
- Article
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1233, doi. 10.1007/s00262-022-03322-1
- By:
- Publication type:
- Article
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 613, doi. 10.1007/s00262-021-02982-9
- By:
- Publication type:
- Article
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 31, doi. 10.1007/s00262-020-02654-0
- By:
- Publication type:
- Article
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5543, doi. 10.3390/cancers13215543
- By:
- Publication type:
- Article
Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0251011
- By:
- Publication type:
- Article
Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. 62, doi. 10.3816/CLML.2010.n.007
- By:
- Publication type:
- Article
Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 5, p. 442, doi. 10.1111/ejh.12513
- By:
- Publication type:
- Article
Re-analysis of the Outcomes of Post-Remission Therapy for Acute Myeloid Leukemia with Core Binding Factor According to Years of Patient Enrolment.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 6, p. 556
- By:
- Publication type:
- Article
18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e189, doi. 10.1016/j.clml.2019.09.317
- By:
- Publication type:
- Article
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e163, doi. 10.1016/j.clml.2019.09.272
- By:
- Publication type:
- Article
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission.
- Published in:
- 2018
- By:
- Publication type:
- journal article